Top Markets
#1 Islamic Coin Islamic Coin +154.29%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +30.82%
#4 RedStone RedStone +16.61%
#5 Bio Protocol Bio Protocol +16.57%
#6 edgeX edgeX +15.25%
#7 rsERG rsERG +12.23%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.05%
#9 SkyAI SkyAI +11.71%
#10 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +11.42%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Level Biotechnology Inc. Level Biotechnology Inc.

Level Biotechnology Inc.

3118
Rang in Aktien #27462
Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan,... Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan, operates in the commercialization and distribution of scientific products and services. The company supplies specialized reagents and consumables for cell culture, immunology, and molecular biology, alongside advanced biomedical instrumentation, throughout Taiwan. Beyond product distribution, Level Biotechnology offers a comprehensive suite of research and testing services. These include expert assessments in mammalian and genetic toxicology, pharmacological studies, biocompatibility testing, and the production of model animals. The firm's preclinical research capabilities serve a diverse range of clients in the biotechnology, pharmaceutical, medical device, animal health, and agrichemical industries.
Aktienkurs
$1.01
Marktkapitalisierung
$32.71M
Veränderung (1 Tag)
0.16%
Veränderung (1 Jahr)
-5.89%
Land
TW
Handel Level Biotechnology Inc. (3118)

Kategorie

Healthcare
P/B-Verhältnis für Level Biotechnology Inc. (3118)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Level Biotechnology Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Level Biotechnology Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH